Compound class:
Synthetic organic
Comment: Compound 1 is reported as an irreversible inhibitor of the M2 splice form of pyruvate kinase (PKM2) [1]. It targets both the metabolic and oncogenic functions of PKM2 and mediates antitumour effects in vitro and in vivo. The covalent PKM2 binding residues have been identified as Cys317 and Cys326 which are close to the enzyme's substrate-binding site.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|